Nadège Pelletier
Directeur Technique/Scientifique/R&D chez BARINTHUS BIOTHERAPEUTICS PLC
Fortune : - $ au 30/04/2024
Postes actifs de Nadège Pelletier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 01/02/2023 | - |
Historique de carrière de Nadège Pelletier
Anciens postes connus de Nadège Pelletier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formation de Nadège Pelletier
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| École Normale Supérieure de Lyon | Graduate Degree |
Statistiques
Internationale
| France | 3 |
| Royaume-Uni | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Bourse
- Insiders
- Nadège Pelletier
- Expérience
